Axis 2
Studiedness
- Evidence amount
- 0.92
- Direction balance
- The direction of the study results has not been extracted.
- PMID records loaded
- 8
- Records after title/year deduplication
- 8
entity · release 2026-09-20
Bifidobacterium bifidum R0071
Structured fields rendered from the release dataset. Unknown values retain a reason; price is outside GIS.
Across the corpus
How this organism is actually sold
- Forms
- Capsule: 1 · counted across the 1 of 1 published products whose label states a form
- Brands carrying it
- viva-naturals (1)
- Published product pages
- 1
Products
Published products carrying this organism
| Product | Printed CFU | Printed dose | Cost per day | Form | Gut Index Score |
|---|---|---|---|---|---|
| Viva Naturals Advanced Probiotics 50 Billion CFU | not printed | not printed | not observed | Capsule | 56.27 |
Containing labels1
Evidence amount0.92
Direction balanceThe direction of the study results has not been extracted.
Matched PubMed records
8 records (retracted records excluded; 0 retracted records match the query separately). PubMed query
Matched records include trials of multi-ingredient products; this is not a count of trials of this entity alone.
- 2021 · Effects of a nine-strain bacterial synbiotic compared to simethicone in colicky babies - an open-label randomised study.
- 2019 · Probiotics maintain intestinal secretory immunoglobulin A levels in healthy formula-fed infants: a randomised, double-blind, placebo-controlled study.
- 2018 · Modulatory effect of three probiotic strains on infants' gut microbial composition and immunological parameters on a placebo-controlled, double-blind, randomised study.
- 2017 · Safety and tolerance of three probiotic strains in healthy infants: a multi-centre randomized, double-blind, placebo-controlled trial.
- 2017 · Effect of probiotics on digestibility and immunity in infants: A study protocol for a randomized controlled trial.
- 2016 · Bifidobacterium bifidum R0071 decreases stress-associated diarrhoea-related symptoms and self-reported stress: a secondary analysis of a randomised trial.
- 2015 · Bifidobacterium bifidum R0071 results in a greater proportion of healthy days and a lower percentage of academically stressed students reporting a day of cold/flu: a randomised, double-blind, placebo-controlled study.
- 2010 · Efficacy of a synbiotic supplementation in the prevention of common winter diseases in children: a randomized, double-blind, placebo-controlled pilot study.
ClinicalTrials.gov
11 interventional studies. ClinicalTrials.gov query
This species has 37 tracked designations; this one appears on 1 labels (median 4).
Species and related strains
Axis 1 · inverted
Containing label versions
Showing 1 of 1 rows, ordered by Gut Index Score descending, then DSLD label ID. Download full CSV · Download full JSON.
| Brand | Product | DSLD | Gut Index Score | Strain named | Per-organism quantity | Potency basis | Versions |
|---|---|---|---|---|---|---|---|
| Viva Naturals | Advanced Probiotics 50 Billion CFU | 247987 | 56.27 | true | not printed for this organism | not stated | 1 |
Axis 3
Measurement integrity
Not a measurement product, so this axis does not apply.
Axis 4
Reddit mention panel
0 observed mentions; no aggregate panel matched this entity.
Elsewhere in this release
Related pages
Findings computed over the whole corpus: Strain naming census · Label designation changes · Strain dose match · Stability literature gaps
Tools: DSLD product check · Unit value calculator
Citation
Cite this page
Ivitskiy, I. (2026). Bifidobacterium bifidum R0071. Gut Registry, release 2026-09-20. Elanvale Ltd. https://gutregistry.com/s/bifidobacterium-bifidum-r0071/
The underlying tables are published under CC BY 4.0: this page as CSV · as JSON · full release and data dictionary. Cell-level provenance names the source record and its observation date.
Citable atoms
Release claims
Bifidobacterium bifidum R0071 appears on 1 of 13,330 labels in the NIH DSLD snapshot (Sep 2026), from 1 brands; tied with 227 designations by distinct label count.
1 / 13330 observed label versions · NIH DSLD snapshot Sep 2026 · entity.prevalence · checked 2026-09-20T00:00:00Z · snapshot b7633f7324370 of 1 containing labels in the NIH DSLD snapshot (Sep 2026) print a quantity for Bifidobacterium bifidum R0071 (0.0%); 0 light records have quantities unavailable.
0 / 1 containing labels · NIH DSLD snapshot Sep 2026 · entity.quantity · checked 2026-09-20T00:00:00Z · snapshot b7633f7324378 PubMed records indexed as human randomized controlled trials match the published query (as of 2026-09-15). 8 records (retracted records excluded; 0 retracted records match the query separately).
8 / 8 loaded PMID records · NIH DSLD snapshot Sep 2026 · entity.evidence · checked 2026-09-20T00:00:00Z · snapshot b7633f73243711 interventional studies on ClinicalTrials.gov match the published query.
Published ClinicalTrials.gov query
11 / Not available in this release. interventional registry studies · NIH DSLD snapshot Sep 2026 · entity.registered_trials · checked 2026-09-20T00:00:00Z · snapshot b7633f7324370 of 1 SKUs containing Bifidobacterium bifidum R0071 have a numeric price observation (0.0%) in the release accompanying the NIH DSLD snapshot Sep 2026.
0 / 1 containing SKUs · NIH DSLD snapshot Sep 2026 · entity.price · checked 2026-09-20T00:00:00Z · snapshot b7633f732437